Clinical Trial Update: A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether ZADAXIN (thymalfasin) can enhance immune response to the H1N1 influenza vaccine in patients with end-stage renal disease; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• ZADAXIN (Thymosin alpha-1)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: END STAGE RENAL DISEASE | Phase 2 | Status: COMPLETED